Xpert® Norovirus

Home / Tests / HAI & Other Infectious Diseases

Xpert® Norovirus

Fast and accurate identification of Norovirus GI & GII in as little as one hour* *With early assay termination for positive results. Reporting negative results in 90 minutes.

Test pack size(s)

10 Tests

GXNOV-CE-10

Qty

Unit price

Subtotal

USD

Collection devices

Single Use Disposable Swab (Pack of 120)

SDPS-120

Qty

Unit price

Subtotal

USD

Total

Error adding items to cart. If this error persists, please contact Digital Support

List name

Label

Having trouble? Contact Cepheid Digital Support

The Need

Norovirus is highly contagious and is the most common cause of acute gastroenteritis worldwide^1,2
Globally, an estimated 685 million cases of norovirus are seen annually, including 200 million cases amongst children under 5^1,2
Norovirus causes an estimated 200,000 deaths per year, including 50,000 child deaths^1,2
Every year, this virus is estimated to cost $60 billion worldwide due to healthcare costs and lost productivity^1,2
Norovirus outbreaks in healthcare institutions require immediate implementation of infection control measures to avoid ward closures^1,2

1 Norovirus Burden and trends, CDC https://www.cdc.gov/norovirus/burden.html#worldwide. Accessed November 22, 2023
2 Norovirus introduction. WHO. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/norovirus. Accessed November 22, 2023

The Solution

Xpert Norovirus detects genotype I (GI) and genotype II (GII), which are responsible for the majority of infections
Xpert Norovirus provides fast and actionable results for clinicians when it is needed most, to timely set up infection control initiative and optimized bed and patient management to reduce the spread of infection³
On-demand identification supports outbreak management enabling fast contact tracing to manage onward transmission⁴

3 Cleary O, et al. Evaluation of the Xpert Norovirus assay for the rapid detection of norovirus genogroups I and II in faecal specimens within a routine laboratory setting. British Journal of Biomedical Science. 2017 Dec:74(3):144-147
4 Salmona M, et al. Laboratory-based strategy using a new marketed polymerase chain reaction assay to manage diarrheic episodes among patients from rehabilitation and long-term care facilities. Am J Infect Control. 2016 Jun 1;44(6):716-8

The Impact

Fast and accurate PCR testing with Xpert Norovirus greatly improves time to result compared to other PCR tests, allowing healthcare professionals to quickly identify, isolate and appropriately manage patients, helping prevent spread³:

89% decrease in turnaround time (22 h versus 2.4 h)⁵
66% reduction in unnecessary isolation⁶
$320,209^ savings by preventing bed closures and unnecessary isolation⁶

3 Cleary O, et al. Evaluation of the Xpert Norovirus assay for the rapid detection of norovirus genogroups I and II in faecal specimens within a routine laboratory setting. British Journal of Biomedical Science. 2017 Dec:74(3):144-147
5 Henningsson AJ, Nilsson Bowers A, Nordgren J, Quttineh M, Matussek A, Haglund S. Rapid diagnosis of acute norovirus-associated gastroenteritis: evaluation of the Xpert Norovirus assay and its implementation as a 24/7 service in three hospitals in Jönköping County, Sweden. Eur J Clin Microbiol Infect Dis. 2017 Oct;36(10):1867-1871
6 Lyer S, et al. Comparative Evaluation 2 Commercial Norovirus Real-time PCR assays for Hospital Outbreak Management. Federation of Infection society p192 11th-14th Nov. 2013
* 57 minutes with early assay termination for positive results
^ Exchange rate December 08, 2023: 1$ = 0,79£